Back
45
Day Range
$68.85
$70.50
52-Week Range
$67.56
$109.50
Volume
8,603,601
50D / 200D Avg
$80.41
/
$95.75
Prev Close
$69.48
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 35.8 | 0.4 |
| P/B | 4.3 | 2.9 |
| ROE % | 12.6 | 3.8 |
| Net Margin % | 14.4 | 3.9 |
| Rev Growth 5Y % | 14.0 | 10.0 |
| D/E | 0.5 | 0.2 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 |
Morano Susan E
Director
|
grant | 24 | — | — |
| Mar 2, 2026 |
Pegus Cheryl
Director
|
grant | 24 | — | — |
| Mar 1, 2026 |
Woodworth Emily
SVP, Global Controller and CAO
|
other | 2,048 | — | — |
| Nov 28, 2025 |
O'Sullivan Miriam
SVP, Chief HR Officer
|
other | 260 | — | — |
| Nov 14, 2025 |
Fitzgerald Joseph Michael
EVP & Group Pres, Cardiology
|
other | 9,610 | — | — |
| Nov 12, 2025 |
Fitzgerald Joseph Michael
EVP & Group Pres, Cardiology
|
other | 690 | — | — |
| Aug 1, 2025 |
LUDWIG EDWARD J
Director
|
other | 500 | — | — |
| Jul 29, 2025 |
FUJIMORI YOSHIAKI
Director
|
sell | 2,901 | $106.99 | $310,378 |
| Jul 1, 2025 |
Monson Jonathan
EVP and CFO
|
grant | 30,523 | — | — |
| May 29, 2025 |
LUDWIG EDWARD J
Director
|
sell | 4,000 | $104.59 | $418,368 |
| May 21, 2025 |
Brown Vance R
SVP, GC and Corp. Secretary
|
sell | 4,826 | $106.42 | $513,583 |
| May 8, 2025 |
Habiger David C
Director
|
grant | 2,081 | — | — |
| May 8, 2025 |
WICHMANN DAVID S
Director
|
grant | 2,081 | — | — |
| May 8, 2025 |
Mega Jessica L
Director
|
grant | 2,081 | — | — |
| May 8, 2025 |
Zane Ellen M
Director
|
grant | 2,081 | — | — |
| May 8, 2025 |
LUDWIG EDWARD J
Director
|
grant | 2,081 | — | — |
| May 5, 2025 |
Sorenson John Bradley
EVP, Global Operations
|
sell | 4,572 | $104.54 | $477,957 |
| May 2, 2025 |
Sorenson John Bradley
EVP, Global Operations
|
other | 10,326 | — | — |
| May 2, 2025 |
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
|
other | 5,221 | — | — |
| Apr 21, 2025 |
Brown Vance R
SVP, GC and Corp. Secretary
|
sell | 4,826 | $95.09 | $458,904 |
Key Takeaways
Revenue grew 13.99% annually over 5 years — strong growth
Earnings grew 55.66% over the past year
ROE of 12.55% — decent returns on equity
Generating 3.66B in free cash flow
P/E of 35.76 — premium valuation
PEG of 0.88 suggests growth is underpriced
Growth
Revenue Growth (5Y)
13.99%
Revenue (1Y)19.87%
Earnings (1Y)55.66%
FCF Growth (3Y)46.56%
Quality
Return on Equity
12.55%
ROIC8.13%
Net Margin14.38%
Op. Margin19.78%
Safety
Debt / Equity
0.51
Current Ratio1.62
Interest Coverage11.38
Valuation
P/E Ratio
35.76
P/B Ratio4.26
EV/EBITDA28.60
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.87% | Revenue Growth (3Y) | 18.73% |
| Earnings Growth (1Y) | 55.66% | Earnings Growth (3Y) | 34.60% |
| Revenue Growth (5Y) | 13.99% | Earnings Growth (5Y) | 29.07% |
| Profitability | |||
| Revenue (TTM) | 20.07B | Net Income (TTM) | 2.89B |
| ROE | 12.55% | ROA | 6.61% |
| Gross Margin | 69.01% | Operating Margin | 19.78% |
| Net Margin | 14.38% | Free Cash Flow (TTM) | 3.66B |
| ROIC | 8.13% | FCF Growth (3Y) | 46.56% |
| Safety | |||
| Debt / Equity | 0.51 | Current Ratio | 1.62 |
| Interest Coverage | 11.38 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 35.76 | P/B Ratio | 4.26 |
| P/S Ratio | 5.14 | PEG Ratio | 0.88 |
| EV/EBITDA | 28.60 | Dividend Yield | 0.00% |
| Market Cap | 103.19B | Enterprise Value | 113.56B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.07B | 16.75B | 14.24B | 12.68B | 11.89B |
| Net Income | 2.89B | 1.85B | 1.59B | 698.00M | 1.04B |
| EPS (Diluted) | 1.94 | 1.25 | 1.07 | 0.45 | 0.69 |
| Gross Profit | 13.85B | 10.27B | 8.83B | 7.71B | 7.46B |
| Operating Income | 3.97B | 2.64B | 2.18B | 1.82B | 1.92B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 43.67B | 39.40B | 35.14B | 32.47B | 32.23B |
| Total Liabilities | 19.20B | 17.39B | 15.61B | 14.90B | 15.61B |
| Shareholders' Equity | 24.23B | 21.77B | 19.28B | 17.57B | 16.62B |
| Total Debt | 12.42B | 11.15B | 9.49B | 9.28B | 9.45B |
| Cash & Equivalents | 2.05B | 414.00M | 865.00M | 928.00M | 1.93B |
| Current Assets | 8.79B | 6.92B | 6.51B | 5.76B | 6.32B |
| Current Liabilities | 5.44B | 6.40B | 4.93B | 3.80B | 4.27B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#521 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026